| Position | Action |
|---|---|
| Current weight above 1.5% of book | Trim to ≤1.5% of book |
| Sustained close above $364 with volume | Add back to ~2% of book |
| Breakdown below $326 with volume | Close entirely |
AXP is a best-in-class 34%-ROE closed-loop payments franchise trading at a relative discount with record Q2 results, raised guidance, aggressive buybacks, and a coiled technical setup offering 7-10:1 reward-to-risk.
| Indicator | Value | Signal |
|---|---|---|
| 50 SMA | 336.50 | bullish |
| 200 SMA | 338.03 | bullish |
| 10 EMA | 342.40 | bearish |
| MACD | +0.64 | neutral |
| MACD Histogram | -0.50 | bearish |
| RSI | 49.35 | neutral |
| Bollinger Upper Band | 364.35 | neutral |
| Bollinger Middle Band | 345.23 | neutral |
| Bollinger Lower Band | 326.10 | neutral |
| ATR | 7.84 | neutral |
| Latest Close | 340.91 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Trim AXP to underweight; exit fully on $326 breakdown or re-engage on $364 breakout
The Underweight rating reflects a deteriorating-but-unconfirmed setup where a 16% drawdown from $387 to $326 has already occurred with Berkshire as anchor, suggesting further downside requires a fresh catalyst. The aggressive analyst correctly identifies franchise quality (34% ROE, Berkshire anchor, structural capital return) as too durable to fade aggressively, but the bear case lacks confirmed breakdown. MACD histogram is recovering (-3.53 to -0.50), RSI is dead neutral at 49.35, and price sits at triple-layered support ($326-336 from 50/200 SMAs and July low). Flat EPS guidance ($17.30-$17.90) despite ~10% revenue acceleration implies H2 deceleration, while the 2023 buyback authorization is essentially complete (74.09M shares/$18.32B), removing the ~$2.3B/quarter tailwind. PEG of 0.94 represents fair value, not a discount. The structural franchise thesis remains intact for re-engagement on confirmation.
When: Breakdown below $326 with volume
Then: Close position entirely
↩ rebuts: “Bear's 'in-line quarter' characterization”
· concedes: The bear correctly identifies short-term technical weakness and rangebound price action; MACD histogram is negative at -0.50; Stock is currently below 10 EMA
AXP is a high-quality franchise trading at a price that already reflects its quality — the technical setup is deteriorating, the buyback tailwind has played out, EPS guidance is flat, and competitive pressure is rising, making the gap between stock quality and stock setup a 10-15% downside risk.
· concedes: The 'mean reversion' thesis has merit as a long-term structural argument — a high-quality franchise at a discount should eventually catch a bid; Berkshire's position does provide a genuine floor against catastrophic downside; The Platinum refresh is a real response to competition, not a non-event; AXP is a high-quality franchise with strong brand and customer base
→ vs conservative: MACD crossover and RSI neutral at 49 misread as bearish; RSI at 49 and converging SMAs indicate a coiled spring pattern, not a breakdown setup
→ vs conservative: Buyback argument mischaracterized as one-time rather than structural capital return policy (75% of net income)
→ vs conservative: Trim-to-$345-$350 plan requires being right twice (bounce then giveback) with poor expected value vs. buying at 200 SMA
→ vs conservative: Stop at $364 (~6% above) on the relief bounce trade provides worse risk-reward than buying at 200 SMA with stop at $326 (~4% downside)
→ vs conservative: SELL recommendation leaves money on the table given record fundamentals, supportive macro, and 3-to-1 reward-to-risk ratio
Support: 336.5 · 338.03 · 326.17 · 326.1 | Resistance: 342.4 · 364.35 · 361.57
AXP trades in a coiled, direction-neutral state with long-term averages (50/200 SMA) providing mild bullish support and near-term momentum (negative MACD histogram, price below 10 EMA) leaning bearish. The 50 SMA (336.50) and 200 SMA (338.03) are converging within ~$1.50 of each other — a classic pre-breakout compression. ATR has contracted from $9.25 (Jul-27) to $7.84, suggesting volatility expansion will accompany the next directional move. The most disciplined posture is HOLD; new longs require a sustained close above 342.40 with positive MACD histogram, while new shorts require a sustained close below 336.50 with widening negative histogram.
Market Cap
$230.2 B
Share Price (50-day avg)
$334.24
Share Price (200-day avg)
$339.50
52-Week High
$387.49
52-Week Low
$290.97
Beta
1.055
P/E (TTM)
20.69x
Forward P/E
16.95x
PEG Ratio
1.63
P/B
6.71x
Dividend Yield
1.11%
Book Value per Share
$50.79
ROE
34.38%
ROA
3.79%
Operating Margin
20.32%
Net Profit Margin
16.14%
Current Ratio
1.553
Debt/Equity
172.4%
FY2025 Revenue
$72.23 B
FY2025 Net Income
$10.83 B
FY2025 Diluted EPS
$15.38
FY2025 Revenue Growth
+9.5% YoY
FY2025 Net Income Growth
+6.9% YoY
FY2025 EPS Growth
+9.8% YoY
3-yr Revenue CAGR
~10.9%
3-yr EPS CAGR
~16.0%
FY2025 Free Cash Flow
$16.00 B
FY2025 Operating Cash Flow
$18.43 B
FY2025 Buybacks
$5.81 B
FY2025 Dividends Paid
$2.27 B
Q2 2026 Revenue
$19.64 B
Q2 2026 Net Income
$3.11 B
Q2 2026 Diluted EPS
$4.53
Q2 2026 YoY EPS Growth
~11%
Q2 2026 Total Assets
$308.2 B
Q2 2026 Cash & Equivalents
$45.2 B
Q2 2026 Total Debt
$59.05 B
Q2 2026 Stockholders' Equity
$34.28 B
Q2 2026 Shares Outstanding
682.3 M
Q2 2026 Net Debt
$13.88 B
FY2025 Net Interest Income
$17.36 B
FY2025 Interest Income
$25.60 B
FY2025 Interest Expense
$8.23 B
FY2025 SG&A
$15.27 B
FY2025 Pretax Income
$13.80 B
FY2025 Tax Rate
21.47%
FY2025 Tangible Book Value
$28.51 B
FY2025 Goodwill
$4.87 B
Strengths
Concerns
AXP is a high-quality premium consumer-finance franchise with industry-leading 34.38% ROE, strong cash generation ($16B FY25 FCF), and accelerating earnings (Q2 2026 record EPS of $4.53 implying ~18% YoY growth). The company is aggressively returning capital through ~$8B+ annually in buybacks and dividends, reducing share count by 8.2% since FY2022. Trading at a forward P/E of 16.95x with modest upside to the 52-week high of $387.49, suggesting fair valuation at current levels; upside requires either an EPS beat or multiple re-rating.